Multispectral label‐free Raman spectroscopy can detect ovarian and endometrial cancer with high accuracy

Up to 70% of ovarian cancer patients are diagnosed with advanced-stage disease and the degree of cytoreduction is an important survival prognostic factor. The aim of this study was to evaluate if Raman spectroscopy could detect cancer from different organs within the abdominopelvic region, including the ovaries. A Raman spectroscopy probe was used to interrogate specimens from a cohort of 9 patients undergoing cytoreductive surgery, including 4 ovarian cancer patients and 3 patients with endometrial cancer. A feature-selection algorithm was developed to determine which spectral bands contributed to cancer detection and a machine-learning model was trained. The model could detect cancer using only 8 spectral bands. The receiver-operating-characteristic (ROC) curve had an area-under-the-curve (AUC) of 0.96, corresponding to an accuracy, a sensitivity and a specificity of 90%, 93% and 88%, respectively. These results provide evidence multispectral Raman spectroscopy could be developed to detect ovarian cancer intraoperatively.

This article is protected by copyright. All rights reserved.

留言 (0)

沒有登入
gif